Correlation Between Enliven Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Enliven Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for Enliven Therapeutics and Terns Pharmaceuticals
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enliven and Terns is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Terns Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 1.3 times less risky than Terns Pharmaceuticals. The stock trades about -0.23 of its potential returns per unit of risk. The Terns Pharmaceuticals is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest 651.00 in Terns Pharmaceuticals on August 28, 2024 and sell it today you would lose (72.00) from holding Terns Pharmaceuticals or give up 11.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Enliven Therapeutics |
| Terns Pharmaceuticals |
Enliven Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite Enliven Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Enliven Therapeutics vs. Capricor Therapeutics | Enliven Therapeutics vs. Soleno Therapeutics | Enliven Therapeutics vs. Bio Path Holdings | Enliven Therapeutics vs. Moleculin Biotech |
| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |